Early Experience with AngioVac Aspiration in the Pulmonary Arteries

Ramsey Al-Hakim, Jonathan Park, Anshuman Bansal, Scott Genshaft, John M. Moriarty

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Five consecutive cases in which the AngioVac aspiration cannula was used for the management of pulmonary embolism (PE) were retrospectively reviewed. Four cases (80%) presented with massive PE, and two (40%) were technically successful (reduction in Miller index ≥ 5). Four patients (80%) died at a mean of 7.3 days after the procedure, including one death related to right ventricular free wall perforation. Although the AngioVac aspiration cannula has shown clinical promise in a variety of clinical applications, early experience in the pulmonary arteries has shown limited success, and further study and careful patient selection are required.

Original languageEnglish (US)
Pages (from-to)730-734
Number of pages5
JournalJournal of Vascular and Interventional Radiology
Volume27
Issue number5
DOIs
StatePublished - May 1 2016
Externally publishedYes

Fingerprint

Pulmonary Embolism
Pulmonary Artery
Patient Selection
Cannula

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Early Experience with AngioVac Aspiration in the Pulmonary Arteries. / Al-Hakim, Ramsey; Park, Jonathan; Bansal, Anshuman; Genshaft, Scott; Moriarty, John M.

In: Journal of Vascular and Interventional Radiology, Vol. 27, No. 5, 01.05.2016, p. 730-734.

Research output: Contribution to journalArticle

Al-Hakim, Ramsey ; Park, Jonathan ; Bansal, Anshuman ; Genshaft, Scott ; Moriarty, John M. / Early Experience with AngioVac Aspiration in the Pulmonary Arteries. In: Journal of Vascular and Interventional Radiology. 2016 ; Vol. 27, No. 5. pp. 730-734.
@article{f46dbb865dfe45e7ad97bdbece25e85d,
title = "Early Experience with AngioVac Aspiration in the Pulmonary Arteries",
abstract = "Five consecutive cases in which the AngioVac aspiration cannula was used for the management of pulmonary embolism (PE) were retrospectively reviewed. Four cases (80{\%}) presented with massive PE, and two (40{\%}) were technically successful (reduction in Miller index ≥ 5). Four patients (80{\%}) died at a mean of 7.3 days after the procedure, including one death related to right ventricular free wall perforation. Although the AngioVac aspiration cannula has shown clinical promise in a variety of clinical applications, early experience in the pulmonary arteries has shown limited success, and further study and careful patient selection are required.",
author = "Ramsey Al-Hakim and Jonathan Park and Anshuman Bansal and Scott Genshaft and Moriarty, {John M.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.jvir.2016.01.012",
language = "English (US)",
volume = "27",
pages = "730--734",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Early Experience with AngioVac Aspiration in the Pulmonary Arteries

AU - Al-Hakim, Ramsey

AU - Park, Jonathan

AU - Bansal, Anshuman

AU - Genshaft, Scott

AU - Moriarty, John M.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Five consecutive cases in which the AngioVac aspiration cannula was used for the management of pulmonary embolism (PE) were retrospectively reviewed. Four cases (80%) presented with massive PE, and two (40%) were technically successful (reduction in Miller index ≥ 5). Four patients (80%) died at a mean of 7.3 days after the procedure, including one death related to right ventricular free wall perforation. Although the AngioVac aspiration cannula has shown clinical promise in a variety of clinical applications, early experience in the pulmonary arteries has shown limited success, and further study and careful patient selection are required.

AB - Five consecutive cases in which the AngioVac aspiration cannula was used for the management of pulmonary embolism (PE) were retrospectively reviewed. Four cases (80%) presented with massive PE, and two (40%) were technically successful (reduction in Miller index ≥ 5). Four patients (80%) died at a mean of 7.3 days after the procedure, including one death related to right ventricular free wall perforation. Although the AngioVac aspiration cannula has shown clinical promise in a variety of clinical applications, early experience in the pulmonary arteries has shown limited success, and further study and careful patient selection are required.

UR - http://www.scopus.com/inward/record.url?scp=84964335911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964335911&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2016.01.012

DO - 10.1016/j.jvir.2016.01.012

M3 - Article

VL - 27

SP - 730

EP - 734

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 5

ER -